S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Biden To Unleash "Choke Point" Operation On America? (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Biden To Unleash "Choke Point" Operation On America? (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Biden To Unleash "Choke Point" Operation On America? (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Biden To Unleash "Choke Point" Operation On America? (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Biden To Unleash "Choke Point" Operation On America? (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Biden To Unleash "Choke Point" Operation On America? (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
S&P 500   3,970.99
DOW   32,237.53
QQQ   310.89
Ukraine demands emergency UN meeting over Putin nuclear plan
Modern Day Options Trading For Beginners! (Ad)pixel
New Russian campaign tries to entice men to fight in Ukraine
Factory or farm? Oregon may alter land use for chipmakers
Biden To Unleash "Choke Point" Operation On America? (Ad)
Travel disruption hits Germany on eve of transport strike
Berlin climate proposal fails to get enough yes votes to win
Biden To Unleash "Choke Point" Operation On America? (Ad)
Adele extends Las Vegas residency, plans concert film
Turkmenistan votes for new, opposition-free parliament
OTCMKTS:DGNOF

DIAGNOS - DGNOF Stock Forecast, Price & News

$0.27
+0.01 (+2.76%)
(As of 03/22/2023)
Add
Compare
Today's Range
$0.27
$0.27
50-Day Range
$0.22
$0.32
52-Week Range
$0.11
$0.32
Volume
7,500 shs
Average Volume
6,705 shs
Market Capitalization
$19.17 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A

DGNOF stock logo

About DIAGNOS (OTCMKTS:DGNOF) Stock

Diagnos, Inc. engages in the provision of healthcare technical services through the use of artificial intelligence (AI). The company offers algorithm development, data analysis, and image processing services. It focuses on the development of its AI tool, Computer Assisted Retina Analysis, which is a tele-ophthalmology platform that integrates with existing equipment and processes at the point of care. The company was founded by Djamel Abdelkader Zighed in 1998 and is headquartered in Brossard, Canada.

Receive DGNOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

DGNOF Stock News Headlines

No headlines for this company have been tracked by MarketBeat.com
Receive DGNOF Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for DIAGNOS and its competitors with MarketBeat's FREE daily newsletter.

DGNOF Company Calendar

Today
3/26/2023
Fiscal Year End
3/31/2023

Industry, Sector and Symbol

Industry
Private households
Sub-Industry
N/A
Current Symbol
OTCMKTS:DGNOF
CIK
N/A
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Net Income
$-2,080,000.00
Net Margins
-445.58%
Pretax Margin
-445.35%
Return on Equity
-30,389.99%

Debt

Sales & Book Value

Annual Sales
$350,000.00

Miscellaneous

Free Float
N/A
Market Cap
$19.17 million
Optionable
Not Optionable
Beta
0.66

Key Executives

  • André M. Larente
    President, Chief Executive Officer & Director
  • Marc-André Massue
    Chief Financial Officer, Secretary & VP-Finance
  • Riadh Kobbi
    Vice President-Business Intelligence
  • Guillermo Moreno Robles
    Vice President-Sales
  • Yves-Stéphane Couture
    Vice President-Sales













DGNOF Stock - Frequently Asked Questions

How have DGNOF shares performed in 2023?

DIAGNOS's stock was trading at $0.2156 at the beginning of 2023. Since then, DGNOF shares have increased by 26.0% and is now trading at $0.2715.
View the best growth stocks for 2023 here
.

Are investors shorting DIAGNOS?

DIAGNOS saw a drop in short interest in the month of February. As of February 15th, there was short interest totaling 500 shares, a drop of 95.8% from the January 31st total of 11,900 shares. Based on an average trading volume of 7,800 shares, the short-interest ratio is presently 0.1 days.
View DIAGNOS's Short Interest
.

What is DIAGNOS's stock symbol?

DIAGNOS trades on the OTCMKTS under the ticker symbol "DGNOF."

How do I buy shares of DIAGNOS?

Shares of DGNOF stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is DIAGNOS's stock price today?

One share of DGNOF stock can currently be purchased for approximately $0.27.

How much money does DIAGNOS make?

DIAGNOS (OTCMKTS:DGNOF) has a market capitalization of $19.17 million and generates $350,000.00 in revenue each year. The company earns $-2,080,000.00 in net income (profit) each year or ($0.04) on an earnings per share basis.

How can I contact DIAGNOS?

DIAGNOS's mailing address is 7005 Taschereau Boulevard Suite 340, Brossard A8, J4Z 1A7. The official website for the company is www.diagnos.ca. The company can be reached via phone at (450) 678-8882.

This page (OTCMKTS:DGNOF) was last updated on 3/27/2023 by MarketBeat.com Staff